CEBPB antibody (AA 1-271)
Quick Overview for CEBPB antibody (AA 1-271) (ABIN165382)
Target
See all CEBPB AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 1-271
-
Purpose
- Human CEBP beta/CEBPB antibody
-
Purification
- Purified
-
Immunogen
- Recombinant human C/EBP-beta (1-271 aa) purified from E. coli
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
- Recommended dilution 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing cycles
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- CEBPB (CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))
-
Alternative Name
- CEBP beta/CEBPB
-
Background
- CCAAT/enhancer-binding proteins (C/EBPs) are a family of basic leucine zipper (bZIP) DNA binding proteins that play important roles in normal cellular differentiation and function in a variety of tissues. The C/EBP family is critical for innate immunity and inflammatory response, and consists of five core members: C/EBPalpha, C/EBPbeta, C/EBPdelta, C/EBPepsilon, and C/EBPgamma. Among these proteins, C/EBPbeta is usually highly expressed in liver, intestine, lung and adipose. C/EBPbeta has three isoforms, two activator, (LAP* and LAP) and a repressor (LIP). These isoforms are differentially translated from the same mRNA. The expression of these isoforms is developmentally and hormonally regulated.
-
NCBI Accession
- NP_005185
-
Pathways
- Interferon-gamma Pathway, Autophagy, Brown Fat Cell Differentiation
Target
-